ArticleResearch square2025
Knowledge, Perspectives, and Risks Perceptions on Gene Drive and Genetically Modified Mosquitoes for Malaria Control among African Stakeholders: A Scoping Review Protocol.
Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
16 authors.
Funding
Abstract
Objective: The objective of this scoping review is to understand the knowledge and perspectives of African stakeholders regarding the use of gene drive mosquitoes in malaria control. Introduction: The prospect of using gene drive and genetically modified mosquitoes as tools for malaria control is generating considerable debate, particularly with regard to its acceptance and implications among key stakeholders, as well as the nature of governance established in its management. This study aims to fill the gaps in understanding the views of African stakeholders on the risks associated with these mosquitoes. Inclusion criteria: This review will include scientific articles and grey literature that explore the knowledge, perspectives, and risks perceptions of African stakeholders on the use of gene drive and genetically modified mosquitoes. Exclusions will apply to documents with restricted access, those addressing diseases other than malaria, and those involving stakeholders outside Africa. Methods: The search will be conducted across PubMed, Embase, Science Direct, Cochrane, and Google Scholar using index terms and keyword strategies tailored to each database. Documents will be selected in four stages: identification, duplicate removal, title and abstract screening, and full-text review for final inclusion. Screening will be conducted on Rayyan by two independent reviewers, with references managed in Zotero. Data extraction will include details on authorship, publication year, study objectives, design, methodology, sample size, findings, conclusions, and limitations. A thematic analysis of the extracted data will be conducted. Discussion: This scoping review will provide a clear understanding of the knowledge, perspectives, and risks perceived by African stakeholders regarding the use of gene drive and genetically modified mosquitoes in malaria control. The results will help to improve communities' engagement, which is crucial to the success of this technology. Registration: This protocol is registered on the Open Science Framework (OSF) (https://osf.io/4kz85).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.